Bloodstream infection profile of COVID-19 patients in intensive care unit of a tertiary care hospital in Western India

---

Original Article

Author Details : Ketaki Niranjan Pathak*, Niranjan P Pathak, Shital Shrikant Ghogale, Savita Jadhav

Volume : 10, Issue : 4, Year : 2024

Article Page : 364-370

https://doi.org/10.18231/j.ijmmtd.2024.061

Suggest article by email

Get Permission

---

Abstract

Background: This study was aimed to determine the pervasiveness, comorbidity and associated risk factors, clinical significance and etiological pathogens of secondary bloodstream infections (BSIs) in COVID-19 patients to start the empirical antimicrobial therapy for positive clinical outcomes.
Materials and Methods: The study was conducted in a tertiary care hospital in Western India during the COVID-19 global pandemic wave (April 2020 to December 2021). COVID-19 status was confirmed by reverse-transcription polymerase chain reaction (RT-PCR). Central line-associated bloodstream infection (CLABSI) was defined according to the NHSN (National Healthcare Safety Network) 2020 criteria. 
Results: Of the 1152 patients admitted to the COVID-19 ICU, 193 (16.7%) developed BSIs, of which 7 (3.6%) had candidemia and 186(96.3%) had bacteremia. A substantial majority of patients had acute respiratory distress syndrome (ARDS) 81(41.9%), while chronic obstructive pulmonary disease (COPD) was present in 46 (23.8%) patients. The most frequent isolates were Klebsiella pneumoniae (52/147, 35.3%) Acinetobacter baumannii (29/147, 19.7%) and E. coli (18/147, 12.2%). Of the total pathogens causing BSI, 128 (66.32%) were multidrug-resistant organisms (MDRO). Methicillin-resistant S. aureus (MRSA) were
19/46 (41.3%) while Enterococcus faecalis were 12/46 (26%).
Conclusion: Appropriate initiation of antibiotic stewardship programmes and strict compliance with the prevention of infections and spread of antibiotic resistance is necessary to contain the transmission of MDROs. A damaging impact on disease management can be expected in seriously ill COVID-19 patients with BSIs caused by MDROs.

.
Keywords : Bloodstream infections (BSIs), COVID­19, ICUs, Multidrug resistance

How to cite : Pathak K N, Pathak N P, Ghogale S S, Jadhav S, Bloodstream infection profile of COVID-19 patients in intensive care unit of a tertiary care hospital in Western India. IP Int J Med Microbiol Trop Dis 2024;10(4):364-370

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.